Literature DB >> 3525365

Intrahepatic cholangiectases and large-duct obliteration in primary sclerosing cholangitis.

J Ludwig, R L MacCarty, N F LaRusso, R A Krom, R H Wiesner.   

Abstract

We studied intrahepatic bile ducts of five patients with chronic ulcerative colitis and primary sclerosing cholangitis. The livers had been obtained at the time of orthotopic liver transplantation. After specimen cholangiography and perfusion fixation, sequential blocks and sections from portal tracts were studied, combining light microscopy with scanning electron microscopy. In vivo cholangiograms were studied also. The specimens revealed: absence of normal bile ducts; presence of thin-walled tubular or saccular cholangiectases with semicircular and annular fibrous crests, without evidence of superinfection; cholangiectases with secondary acute or chronic-cellular cholangitis, with or without cholangitic abscesses; fibrous cholangitis without ductal dilatation; transformation of bile ducts into fibrous cords which were either solid or contained remnants of bile duct epithelium, and complete loss of bile ducts. The shape and distribution of the cholangiectases suggested that these lesions were manifestations of the disease process and not passively dilated normal ducts. Fibrous-obliterative cholangitis with formation of fibrous cords was found not only at the level of interlobular and adjacent septal bile ducts but also at the level of segmental bile ducts that normally would have been demonstrable in cholangiograms. The "pruned-tree" appearance in cholangiograms appears to result from the transition between patent and often cholangiectatic ducts, and duct obliteration. At present, intrahepatic cholangiectases in association with duct obliteration can be considered pathognomonic morphologic features of primary sclerosing cholangitis.

Entities:  

Mesh:

Year:  1986        PMID: 3525365     DOI: 10.1002/hep.1840060403

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  8 in total

1.  Sclerosing cholangitis in baboons (Papio spp) resembling primary sclerosing cholangitis of humans.

Authors:  A M Arenas-Gamboa; J J Bearss; G B Hubbard; B F Porter; M A Owston; E J Dick
Journal:  Vet Pathol       Date:  2011-09-20       Impact factor: 2.221

Review 2.  Primary sclerosing cholangitis: updates in diagnosis and therapy.

Authors:  Piero Portincasa; Michele Vacca; Antonio Moschetta; Michele Petruzzelli; Giuseppe Palasciano; Karel J van Erpecum; Gerard P van Berge-Henegouwen
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

3.  Bile duct antibodies crossreacting with blood group antigens in primary sclerosing cholangitis.

Authors:  G P Jeffrey; N R Swanson; L J Yarred; W D Reed
Journal:  Gut       Date:  1990-06       Impact factor: 23.059

4.  Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.

Authors:  J A Goss; C R Shackleton; D G Farmer; W S Arnaout; P Seu; J S Markowitz; P Martin; R J Stribling; L I Goldstein; R W Busuttil
Journal:  Ann Surg       Date:  1997-05       Impact factor: 12.969

5.  Histological and immunohistochemical study of the gall bladder lesion in primary sclerosing cholangitis.

Authors:  G P Jeffrey; W D Reed; S Carrello; K B Shilkin
Journal:  Gut       Date:  1991-04       Impact factor: 23.059

6.  Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis.

Authors:  K M Abu-Elmagd; M Malinchoc; E R Dickson; J J Fung; P A Murtaugh; A L Langworthy; A J Demetris; R A Krom; D H Van Thiel; T E Starzl
Journal:  Surg Gynecol Obstet       Date:  1993-10

7.  A longitudinal study of histologic and immunohistologic changes in an experimental model of sclerosing cholangitis.

Authors:  P Bedossa; S Houry; J Bacci; E Martin; G Lemaigre; M Huguier
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

8.  Overlapping of primary biliary cirrhosis and small duct primary sclerosing cholangitis: first case report.

Authors:  Elze Maria Gomes Oliveira; Patricia Marinho Oliveira; Vitoria Becker; Alessandra Dellavance; Luis Eduardo Coelho Andrade; Valeria Lanzoni; Antonio Eduardo Benedito Silva; Maria Lucia Gomes Ferraz
Journal:  J Clin Med Res       Date:  2012-11-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.